Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (931-940 of 996) with videos related to

Pageof 100
Sort By:
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLCLuis Paz-Ares, Remi Veillon, Margarita Majem, et al.
Clinical Lung Cancer|March 10, 2026
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA StudyAnna Minchom, Byoung Chul Cho, Natasha B Leighl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2023
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 TrialPaolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, et al.
Cell Reports|April 12, 2018
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor RecurrenceCamila Ferreira de Souza, Thais S Sabedot, Tathiane M Malta, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational ResearchNabil Dib, Philippe Menasche, Jozef J Bartunek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung CancerLeora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung CancerMichael R Shafique, Terrence L Fisher, Elizabeth E Evans, et al.
BMC Ecology|March 22, 2016
Skeletal light-scattering accelerates bleaching response in reef-building coralsTimothy D Swain, Emily DuBois, Andrew Gomes, et al.
Pageof 100

Showing results (931-940 of 996) with videos related to

Sort By:
Pageof 100
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLCLuis Paz-Ares, Remi Veillon, Margarita Majem, et al.
Clinical Lung Cancer|March 10, 2026
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA StudyAnna Minchom, Byoung Chul Cho, Natasha B Leighl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2023
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 TrialPaolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, et al.
Cell Reports|April 12, 2018
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor RecurrenceCamila Ferreira de Souza, Thais S Sabedot, Tathiane M Malta, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational ResearchNabil Dib, Philippe Menasche, Jozef J Bartunek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung CancerLeora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung CancerMichael R Shafique, Terrence L Fisher, Elizabeth E Evans, et al.
BMC Ecology|March 22, 2016
Skeletal light-scattering accelerates bleaching response in reef-building coralsTimothy D Swain, Emily DuBois, Andrew Gomes, et al.
Pageof 100